GILD Gilead Sciences, Inc.
Five-factor quant read, peer ranking, and the analyst team's own call.
priced for 2.9% growth vs 2.6% delivered · +627% to base-case fair value
Piotroski 8/8 · Altman safe zone · ROE 38% · interest covered 11x
running hot on RSI · pressing its 52-week high
Descriptive, not predictive. Momentum, Defensive and Tactical are deciles within our liquid universe; Value and Quality are computed from filed financials. None of them forecasts a return - the model's out-of-sample AUC is published in the whitepaper. Deciles as of 2026-09-02.
Peer comparison
Composite score against sector peers · 5 names
GILD ranks #2 of 5 · peer average 6.4
Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.